sequenc
vari
degre
crossreact
among
ebov
speci
filovirus
envelop
nonseg
negativestrand
rna
virus
filoviru
particl
take
varieti
form
circular
shape
prototyp
straight
filament
viru
famili
name
fig
although
length
virion
variabl
marv
particl
averag
close
nm
ebov
virion
measur
diamet
filoviru
particl
uniformli
measur
nm
filoviru
particl
contain
approxim
noninfecti
genom
encod
seven
structur
protein
gene
order
leader
nucleoprotein
np
virion
protein
glycoprotein
gp
rnadepend
rna
polymeras
l
protein
trailer
four
protein
associ
viral
genom
rna
ribonucleoprotein
complex
np
l
protein
protein
ribonucleoprotein
complex
addit
function
exampl
shown
act
interferon
antagonist
serv
matrix
protein
mediat
particl
format
case
marv
also
shown
interfer
host
innat
immun
respons
anoth
structur
protein
associ
membran
also
interfer
interferon
signal
ebov
gp
surfac
glycoprotein
form
spike
virion
effector
receptor
bind
membran
fusion
import
distinct
ebov
marv
marv
gp
encod
singl
open
read
frame
orf
wherea
ebov
gp
encod
two
orf
singl
marv
orf
translat
structur
surfac
gp
contrast
two
ebov
orf
link
togeth
slippag
l
polymeras
edit
site
string
seven
consecut
templat
uracil
residu
insert
eighth
uracil
process
result
product
messeng
rna
mrna
former
yugoslavia
among
laboratori
worker
expos
blood
tissu
product
african
green
monkey
import
uganda
fig
secondari
transmiss
medic
staff
famili
member
also
document
total
patient
becam
infect
patient
die
next
decad
marv
associ
sporad
isol
usual
fatal
case
among
resid
travel
southeast
africa
prolong
outbreak
involv
case
marv
hemorrhag
fever
hf
durba
democrat
republ
congo
drc
associ
individu
work
underground
gold
mine
casefat
rate
outbreak
unclear
may
outbreak
uniqu
complic
fact
multipl
introduct
marv
differ
phylogenet
lineag
includ
strain
thought
pathogen
angola
other
largest
lethal
marv
outbreak
date
occur
northern
angola
outbreak
involv
case
casefat
rate
epidem
driven
larg
nosocomi
transmiss
howev
communityacquir
infect
document
toward
end
outbreak
sever
small
episod
marv
hf
report
uganda
one
case
export
unit
state
one
netherland
ebola
hemorrhag
fever
ebov
first
recogn
nearsimultan
explos
outbreak
small
commun
former
zair
drc
sudan
see
fig
signific
secondari
transmiss
reus
unsteril
needl
syring
nosocomi
contact
independ
outbreak
involv
serolog
distinct
speci
zebov
sebov
zebov
outbreak
consist
case
death
mortal
wherea
sebov
outbreak
involv
case
death
mortal
sinc
zebov
appear
sporad
central
africa
caus
sever
smallto
midsiz
outbreak
larg
epidem
zebov
hf
involv
case
casefat
rate
kikwit
commun
drc
transcript
permit
readthrough
translat
fulllength
gp
howev
mrna
transcript
edit
translat
structur
surfac
gp
remain
unedit
mrna
transcript
result
product
truncat
solubl
gp
sgp
secret
larg
quantiti
infect
cell
although
function
sgp
fulli
elucid
postul
sgp
subvert
host
immun
respons
passiv
absorb
antibodi
direct
fulllength
structur
gp
trigger
prolifer
b
cell
preferenti
bind
sgp
first
document
outbreak
vhf
caus
filoviru
occur
three
concurr
episod
lethal
marv
infect
marburg
frankfurt
germani
belgrad
includ
immunofluoresc
antibodi
test
enzymelink
immunosorb
assay
filoviru
antigen
specif
immunoglobulin
igm
igg
antibodi
reversetranscriptas
polymeras
chain
reaction
assay
assay
use
confirm
filoviru
infect
includ
immunohistochemistri
skin
tissu
viru
cultur
electron
microscopi
pathogenesi
filovirus
thought
enter
host
mucos
surfac
small
abras
andor
tear
skin
parenter
introduct
ebov
marv
broad
cell
tropism
infect
wide
varieti
cell
type
ultrastructur
examin
tissu
fatal
human
case
experiment
infect
nonhuman
primat
show
monocyt
macrophag
dendrit
cell
endotheli
cell
fibroblast
hepatocyt
adren
cortic
cell
sever
type
epitheli
cell
lend
support
replic
virus
systemat
studi
nonhuman
primat
experiment
infect
marv
zebov
suggest
monocyt
macrophag
dendrit
cell
earli
prefer
replic
site
filoviru
infect
mononuclear
phagocyt
appear
trigger
cascad
event
involv
product
releas
procoagul
protein
tissu
factor
well
varieti
proinflammatori
cytokin
chemokin
oxygen
free
radic
thought
trigger
chain
event
equal
fact
critic
develop
observ
patholog
structur
damag
induc
directli
actual
process
viral
replic
host
cell
andor
tissu
meanwhil
smaller
outbreak
caus
zebov
gabon
sinc
nearyearli
occurr
zebov
gabon
drc
republ
congo
zebov
outbreak
report
first
time
west
africa
countri
guinea
liberia
sierra
leon
central
africa
outbreak
zebov
also
involv
catastroph
declin
popul
great
ape
largest
ebov
outbreak
record
involv
case
casefat
rate
third
speci
ebov
rebov
appear
reston
virginia
associ
outbreak
vhf
among
cynomolgu
macaqu
import
unit
state
philippin
island
hundr
monkey
infect
high
mortal
outbreak
human
case
occur
four
anim
caretak
seroconvert
rebov
overt
diseas
epizoot
cynomolgu
monkey
recur
facil
europ
unit
state
subsequ
rebov
found
philippin
sever
occas
surpris
report
document
infect
domest
pig
fourth
speci
ebov
ciebov
identifi
divoir
viru
isol
ethnologist
work
tai
forest
reserv
becam
infect
necropsi
chimpanze
individu
becam
ill
symptom
consist
filoviru
infect
surviv
infect
chimpanze
origin
troop
lost
sever
member
ill
subsequ
identifi
caus
ciebov
latest
fifth
speci
ebov
bebov
discov
uganda
late
outbreak
involv
confirm
case
approxim
casefat
rate
recent
outbreak
bebov
occur
late
drc
involv
probabl
case
casefat
rate
human
nonhuman
primat
suscept
filoviru
infect
consid
end
host
rather
potenti
reservoir
survey
identifi
anim
reservoir
arthropod
vector
aggress
undertaken
endem
area
particularli
larg
filoviru
outbreak
recent
effort
unsuccess
ecolog
studi
gabon
republ
congo
demonstr
initi
evid
presenc
zebov
three
differ
speci
fruit
bat
studi
show
presenc
viral
rna
antibodi
although
investig
unabl
isol
infecti
zebov
subsequ
studi
detect
marv
rna
isol
infecti
marv
cavedwel
fruit
bat
uganda
support
view
bat
may
serv
reservoir
filovirus
recent
antibodi
rebov
detect
fruit
bat
philippin
although
current
data
suggest
role
bat
maintain
filovirus
natur
remain
unclear
whether
bat
serv
primari
reservoir
whether
speci
involv
clinic
laboratori
featur
marv
ebov
infect
nonspecif
includ
incub
period
day
mean
day
sudden
onset
fever
malais
andor
myalgia
may
includ
varieti
nonspecif
symptom
presenc
erythemat
maculopapular
rash
may
observ
fig
constel
coagul
disord
may
occur
includ
bleed
venipunctur
site
gastrointestin
tract
see
fig
clinic
patholog
find
includ
leukopenia
lymphocytopenia
increas
level
neutrophil
thrombocytopenia
increas
serum
level
liverassoci
enzym
aspart
aminotransferas
alanin
aminotransferas
prolong
blood
coagul
time
increas
circul
level
ddimer
also
associ
filoviru
infect
confirm
filoviru
infect
requir
detect
viru
blood
tissu
demonstr
filovirusspecif
antibodi
assay
frequent
use
diagnos
filoviru
infect
past
littl
commerci
interest
develop
vaccin
filovirus
primarili
geograph
locat
epidem
area
small
global
market
howev
rel
recent
classif
filovirus
import
biolog
defens
pathogen
bolster
increas
press
coverag
latest
outbreak
central
africa
dramat
chang
perspect
regard
need
vaccin
ebov
marv
effect
fastact
filoviru
vaccin
would
valuabl
atrisk
medic
personnel
first
respond
militari
staff
research
also
target
vaccin
affect
popul
eg
primarili
health
care
worker
famili
member
confirm
probabl
case
although
approv
vaccin
postexposur
treatment
modal
avail
prevent
manag
filoviru
infect
least
seven
differ
vaccin
system
shown
promis
complet
protect
nonhuman
primat
either
ebov
marv
hf
five
vaccin
protect
anim
ebov
marv
sever
vaccin
requir
multipl
inject
confer
protect
efficaci
howev
set
pathogen
ebov
marv
indigen
africa
also
potenti
agent
bioterror
singleinject
vaccin
prefer
case
prevent
natur
infect
multipledos
vaccin
costli
practic
logist
complianc
develop
countri
case
deliber
releas
agent
would
littl
time
deploy
vaccin
requir
multipl
inject
extend
period
time
thu
practic
applic
vaccin
filovirus
necessit
singl
immun
two
inject
within
short
time
frame
prospect
filoviru
vaccin
two
system
one
base
replicationdefect
adenoviru
serotyp
base
recombin
vesicular
stomat
viru
vsv
shown
provid
complet
protect
nonhuman
primat
administ
singleinject
vaccin
note
develop
prevent
filoviru
vaccin
confer
complet
protect
nonhuman
primat
model
filoviru
infect
encourag
howev
mani
challeng
remain
vaccin
readi
human
use
even
phase
clinic
trial
among
signific
obstacl
identif
seemingli
pathogen
strain
marv
strain
angola
identif
new
speci
ebov
bebov
filoviru
vaccin
develop
primarili
focus
two
ebov
speci
sebov
zebov
one
marv
strain
strain
musok
howev
recent
studi
shown
current
vaccin
complet
protect
nonhuman
primat
diseas
death
challeng
bebov
addit
vaccin
evalu
seemingli
pathogen
angola
strain
marv
associ
casefat
rate
human
shown
faster
diseas
cours
macaqu
marv
strain
treatment
time
treat
patient
infect
ebov
marv
endem
area
consist
primarili
intens
support
care
direct
toward
maintain
effect
blood
volum
electrolyt
balanc
sever
intervent
therapi
includ
interferon
heparin
convalesc
serum
equin
antizebov
igg
use
treat
natur
laboratoryacquir
filoviru
infect
littl
success
includ
russian
laboratori
exposur
patient
unsuccess
treat
shortli
exposur
combin
therapi
includ
antizebov
equin
igg
ribavirin
reaferon
recent
laboratori
exposur
zebov
germani
treat
recombin
vsvbase
zebov
vaccin
individu
surviv
evid
overt
clinic
ill
howev
whether
patient
actual
expos
zebov
remain
uncertain
ribavirin
use
treat
sever
vhf
vitro
vivo
effect
filovirus
number
postexposur
treatment
shown
promis
nonhuman
primat
model
filoviru
infect
includ
drug
filoviru
infect
lymphoid
deplet
necrosi
frequent
observ
spleen
thymu
lymph
node
patient
fatal
diseas
nonhuman
primat
experiment
infect
fig
although
lymphoid
tissu
primari
site
filoviru
infect
usual
littl
inflammatori
cellular
respons
infect
tissu
despit
larg
dieoff
loss
lymphocyt
diseas
cours
lymphocyt
support
product
progeni
viru
larg
number
lymphocyt
undergo
apoptosi
human
experiment
infect
nonhuman
primat
part
explain
progress
lymphopenia
lymphoid
deplet
death
morpholog
lesion
includ
focal
necrosi
number
organ
particularli
liver
councilman
bodi
promin
find
see
fig
coagul
disord
hallmark
featur
filoviru
infect
result
mani
studi
shown
biochem
histolog
evid
dissemin
intravascular
coagul
human
experiment
infect
nonhuman
primat
mechan
respons
trigger
coagul
disord
typifi
filoviru
infect
complet
understood
result
sever
studi
strongli
suggest
express
releas
tissu
factor
monocyt
macrophag
infect
filovirus
play
pivot
role
induc
develop
coagul
irregular
report
filoviru
hf
howev
coagulopathi
note
ebov
marv
hf
could
caus
sever
factor
especi
later
stage
diseas
monoclon
antibodi
demonstr
abil
protect
macaqu
lethal
marv
andor
zebov
infect
sever
differ
current
studi
includ
specif
reagent
use
regimen
treatment
challeng
virus
use
import
known
earli
studi
use
wildtyp
zebov
isol
consist
high
popul
virus
contain
seri
consecut
uracil
gp
gene
edit
site
mean
isol
produc
normal
amount
sgp
contrast
known
least
two
recent
studi
use
variant
zebov
contain
high
popul
addit
uracil
residu
gp
gene
edit
site
mean
least
earli
stage
replic
viru
produc
much
sgp
wildtyp
zebov
futur
studi
need
fulli
assess
potenti
antibodybas
therapi
seemingli
pathogen
wildtyp
zebov
isol
modul
coagulopathi
includ
inhibitor
tissu
factor
pathway
improv
surviv
macaqu
model
zebov
hf
drug
treat
protein
c
defici
recombin
vsvbase
vaccin
shown
good
result
nonhuman
primat
administ
shortli
challeng
result
rang
protect
zebov
protect
sebov
marv
rnabas
treatment
includ
small
interf
rna
antisens
oligonucleotid
also
shown
abil
confer
protect
death
zebov
marv
given
shortli
challeng
consider
controversi
regard
use
antibodybas
treatment
earli
studi
use
convalesc
blood
hightit
polyclon
equin
igg
human
recombin
monoclon
antibodi
fail
show
benefici
effect
zebov
nonhuman
primat
howev
recent
studi
use
purifi
polyclon
nonhuman
primat
igg
pool
recombin
